![]() |
![]() |
The onchocerciasis program continued
its productive activities on the biological and biochemical characterization
of the parasite Onchocerca volvulus and on the immunological aspects
of the interaction of O. volvulus and Litomosoides sigmodontis
with their immunocompetent hosts. The enthusiasm shared between the members
of the various groups resulted in the exchange of ideas, methodologies
and in productive collaborations. These combined efforts increased our
knowledge of the parasite further and helped to understand important aspects
of host parasite interactions. Members of the program were invited to national
and international meetings and in addition to support from the institute,
researchers of the program managed to attract extramural funds from both
national and international sources.
Novel filarial molecules have been
identified, that may aid in detoxifying activities and tissue modification.
A peroxidoxin protein which displays antioxidative activity was cloned
and recombinantly expressed and similarly an elastine like protease of
low molecular weight was shown to be released by microfilaria.
A further progress during the last
months was the characterization of the intracellular bacteria in O.
volvulus and in L. sigmodontis. Based on the identified bacterial
molecules, these intracellular organisms are identified to the genus Wolbachia.
The role of these intracellular bacteria is currently studied in more detail
and a tetracycline based therapy used in an animal model destroyed the
endobacteria and resulted in filarial infertility.
Additional work concentrated on
PCR-based diagnosis of microfilaria in the skin of infected individuals,
for the discrimination of anthrophilic and zoophilic population of the
Simulium damnosum complexes and on the characterization of the immundiagnostic
potential of recombinant O. volvulus proteins. Due to the lack of
potent and safe drugs against onchocerciasis and lymphatic filariasis studies
of the polyamine metabolism of filarial worms were continued. The potential
of S-adenosylmethionine decarboxylase as target for drug development was
pursued by expression analysis on a molecular and the whole parasite level.
A large panel of antigens has been
identified and cloned during the existence of the onchocerciasis program.
The functional characterization of the corresponding proteins, the knowledge
about their pattern of regulation, their site of expression within the
parasite in combination with the immune profile elicited in the human host,
provides an excellent basis to select proper molecules for vaccine and
drug development. The test of these antigens or of antigenic peptides in
animal models will help to identify protective proteins that may be used
for a vaccine against onchocerciasis.
Peter F. Zipfel
| Staff
Privatdozent Dr. Peter F. Zipfel, Parasitology, Coordinator
Visiting Scientists
Doctoral Students
Graduate Student
Support Staff
|
Polytene chromosomes II (long arm)
of larvae of sympatric populations of Simulium damnosum s.l. cytotypes
(A) `Nyamagasani´ (standard for East Africa), (C) `Nkusi´ with
inversion IIL-5 and (B) a heterozygote with a loop containing both standard
and IIL-5 from river Mahoma in West Uganda. Only `Nyamagasani´ is
highly anthropophilic and a vector of Onchocerca volvulus in East
Africa.
Photo: Andreas Krüger
|